Dedicated to the improvement of lifestyle through wearable technology
We are experts in the design and manufacture of high performance wearables for demanding applications where precision and accuracy matter. Whether its continuos monitoring of a patient to assess their condition, or a training aid to help an athlete realize their full potential, Sensoplex’s relentless pursuit of higher accuracy and specificity makes our solutions both practical and invaluable. Our advanced algorithms and high accuracy processing translate reams of data into concise actionable information, allowing you to achieve what you do best.
Meet the team
Dr. Hamid Najafi, Ph.D
Co-Founder, CEO & CTO, Board Member, Sensoplex
Dr. Hamid Najafi is currently the CEO of Sensoplex, Inc. a company specialized in development of wearables, software, and algorithms for high precision applications, which he co-founded in 2012. Prior to Sensoplex, he was General Manager of Invensense International and Sr. Director of Applications Engineering at Invensense, a leading Silicon Valley manufacturer of MEMS motion sensors.
He co-founded Broadlink Research Inc. in 2005 which developed the first Disney Mobile phone which was marketed by Vodafone in Europe. He also invented the first fully integrated cellular signal repeater for consumer applications.Hamid was the founder of Wireless Link which was a developer of advanced wireless products. The company was sold to CSI Wireless of Canada in 2000 and he served as the CTO of the new entity for 3 years.
He has 14 patents and 5 more pending. Hamid received his Ph.D. In Electrical Engineering from Stanford University in 1983.
Chief Marketing and Business Development Officer, Sensoplex
Graham Loveridge has over 25 years of experience in the consumer electronics and semiconductor markets. Prior to joining Sensoplex he served as the Senior Vice President of Strategic Marketing and Business Development at Pixelworks, a video processing company. In this role, he successfully transitioned the core business from projector and TV to include mobile display processing and IP core licensing. Graham has held VP of Marketing positions at Analogix and Genesis Microchip. At both companies, he was successful in strengthening and spurring business growth which ultimately resulted their acquisition. Mr. Loveridge also served as Director of Marketing for STMicroelectronics and co-founded Cyphort, an advanced persistent threat security company which won SC magazine’s prize for best enterprise security solution.
He holds a Bachelor of Engineering from the university of Teesside in the United Kingdom.
Co-Founder, Chairman & Board Member, Sensoplex
Hamid Farzaneh is a veteran Silicon Valley CEO passionate about building innovative high tech companies. He is a charismatic and high energy leader who believes in the business philosophy of “differentiate or die”. He focuses on empowering teams of outstanding people and driving for time-to-market and complete customer satisfaction.
Hamid co-founded Alea Labs, Inc. in 2015 to develop and market products aiming at making the archaic HVAC industry smart, user-friendly and energy frugal. Prior to Alea, he had co-founded Sensoplex in 2012 to create manufacturing-ready platforms that enabled entrepreneurs to bring innovative “Wearables” products to market in record time. Prior to Sensoplex, Hamid was CEO of Optilux, of Varioptic and of DisplayLink, COO at Atheer, Motion Sense & Genesis Microchip, and EVP at Silicon Optix.
Hamid holds a Master of Science degree in Mechanical Engineering from the Institut National des Sciences Appliquées of Lyon, France and an MBA from Golden Gate university of San Francisco, CA.
Dr. Mehrdad Shamloo, Ph.D
Associate Professor of Neurosurgery, Stanford Neurosciences Institute
Dr. Mehrdad Shamloo received his doctoral degree in 1999 from the Wallenberg Neuroscience Center of Lund University in Sweden. He was recruited to the San Francisco Bay Area the same year where he held several positions at biopharmaceutical companies, including Affymax and AGY Therapeutics, until 2008. During this time he was responsible for the discovery and development of novel neuroprotective and regenerative small molecule and peptide therapeutics for multiple diseases. As the program leader for neuroprotection and regeneration programs at AGY Therapeutics, his work enabled several patent applications, scientific publications, and an IND application and subsequent clinical trials. These years of experience in industry built on his extensive background in CNS drug discovery and preclinical development.
In 2008, Mehrdad joined Stanford University to establish a new behavioral neuropharmacology center for the neuroscience institute. He also formed his own research laboratory to focus on understanding normal and pathological brain functions for neurological disorders such as stroke, Alzheimer’s disease (AD), and autism. Efforts are currently directed towards a subset of genes and proteins involved in neuroprotective or neurodegenerative pathways, which are regulated in these disorders. Through these investigations, Mehrdad and his team hope to understand the processes leading to the functional and behavioral malfunction in these disorders and develop experimental therapeutics. The ultimate goal is to accelerate the translation of these experimental discoveries into novel therapeutic approaches, to improve the quality of life for patients with brain disorders.
Nicholas C Anderson
Payer Approval Specialist, Health & Medical Technology Analyst
Nic is a Health Economist and Medical Technology Analyst from Salt Lake City, Utah who works full-time as a Payer determining which medical technologies are paid for. He is also a consultant to Venture Capitalists and start-ups who are working on new life science products helping them identify what health insurance companies and hospitals want in a technology and for what they’re willing to pay. Nic is also a Strategic Advisor to a number of medical technology companies. He is a guest lecturer at UCSF School of Medicine, University of Utah and at conferences and symposiums where he speaks on clinical trials, HEOR and reimbursement.
Dr. Leslie Torburn, MD
Physical Therapist, 30 years motion analysis
Dr. Leslie Torburn has been a physical therapist for over 30 years. She has worked in motion analysis laboratories for most of her career, beginning as a research physical therapist working closely with Dr. Jacquelin Perry at Rancho Los Amigos National Rehabilitation Center. She has numerous publications in the areas of gait and movement analysis.
She is currently on staff at the Motion Analysis Laboratory of a major children’s hospital in northern California. Dr. Torburn received her Master of Science in Physical Therapy from the University of Southern California and her Doctor of Physical Therapy from Temple University.
Advisor & Board Member, Sensoplex
Michael Minkevich is a seasoned international hi-tech executive with diverse background that covers multiple functional areas and industry verticals, including Telecommunication, Software, Automotive, Energy & Utilities, Digital Media and IoT. Throughout his career, Michael held various executive positions at the global IT/software services companies. In his most recent role at Luxoft (NYSE:LXFT) he was responsible for the company’s global product engineering organization and was instrumental in making it a recognized leader in the product development services.
Currently Michael is a venture partner at Maxfield Capital, a boutique VC fund that focuses on emerging technology companies related to IoT, artificial intelligence, telecommunications, cybersecurity and digital health. He also serves as a board member of several early stage startups.
Michael has in-depth knowledge of all aspects of system engineering and product development lifecycle as well as good understanding of the contemporary technology landscape in the context of multiple industry verticals. He is also helping enterprise customers and smaller startups with development and implementation of their outsourcing strategies. Michael holds a Master of Computer Science degree from Novosibirsk State Technical University and completed business studies at Stanford GSB and MIT.
Dr. Jaime Tenedorio
Medical Device Commercialization, CEO, Scanadu
Advisor & Board Member, Sensoplex
Dr. Jaime Tenedorio has been an executive and co-founder at a number of start-ups in the health and medical arenas and been a key participant in many mergers, acquisitions and fund raising activities for a broad variety of companies. He has served as a CTO, COO and VP level executive at a number of Silicon Valley companies where he was responsible for defining and implementing technology strategy, product direction and development of products for the Wireless Communications, Medical and Consumer Electronics markets.
Jaime is currently the CEO of Scanadu which makes medical technology devices for consumers, combining a broad array of technologies and sensors with intelligent algorithms to create FDA cleared products.
Jaime earned his Bachelors, Masters and PhD degrees in Electrical Engineering at Cornell University. He serves on the boards of two Silicon Valley companies in the technology and medical arenas.